Terms: = Skin cancer AND TRA AND Treatment
4 results:
1. [Surgical treatment of patients with chest malignancies in anti-tuberculosis hospital].
Nekrasov EV; Sinitsyn MV; Didenko GV; Vorobev AA; Ivanova DA
Khirurgiia (Mosk); 2023; (7):12-19. PubMed ID: 37379401
[TBL] [Abstract] [Full Text] [Related]
2. Economic Evaluation of Three BRAF + MEK Inhibitors for the treatment of Advanced Unresectable Melanoma With BRAF Mutation From a US Payer Perspective.
Halloush S; Alkhatib NS; Almutairi AR; Calamia M; Halawah H; Obeng-Kusi M; Hoyle M; Rashdan O; Koeller J; Abraham I
Ann Pharmacother; 2023 Sep; 57(9):1016-1024. PubMed ID: 36639851
[TBL] [Abstract] [Full Text] [Related]
3. A Network Meta-Analysis of Short and Long-Term Efficacy of Targeted Therapy With Single or Double-Drug Regimens in the treatment of Stage III/IV Malignant Melanoma Based on 16 Randomized Controlled Trials.
Xie T; Huang CY; Kang X; Luo JS; Qin XM; Han F
J Cell Biochem; 2018 Jan; 119(1):640-649. PubMed ID: 28628251
[TBL] [Abstract] [Full Text] [Related]
4. Vemurafenib-resistant BRAF-V600E-mutated melanoma is regressed by MEK-targeting drug trametinib, but not cobimetinib in a patient-derived orthotopic xenograft (PDOX) mouse model.
Kawaguchi K; Murakami T; Chmielowski B; Igarashi K; Kiyuna T; Unno M; Nelson SD; Russell TA; Dry SM; Li Y; Eilber FC; Hoffman RM
Oncotarget; 2016 Nov; 7(44):71737-71743. PubMed ID: 27690220
[TBL] [Abstract] [Full Text] [Related]
